In order for the sponsor to assess all potentially relevant safety information, the investigator should, as a rule, report to him all serious adverse events.
Recital 40, Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…
In forcesince 16 Apr 2014